Elena Fedorovna Kovzel

Elena Fedorovna Kovzel

Auto-generated profile, based on publicly available information

Elena Fedorovna Kovzel

Corporate Foundation "University Medical Center", Clinical Immunology and Allergology Program, Astana, Kazakhstan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
PDF file
EKElena Fedorovna Kovzel
Elena Fedorovna Kovzel
BGBayan Gani
Bayan Gani
AZAdil Abusalimovich Zhamankulov
Adil Abusalimovich Zhamankulov
ABAssel Kuatovna Baigojayeva
Assel Kuatovna Baigojayeva
Nijmegen syndrome is a primary immunodeficiency characterized by chromosomal instability, microcephaly, physical retardation, specific disorders of the facial skeleton, as well as a predisposition to cancer. Most patients of Slavic origin have a homozygous mutation with the del5 founder effect in the NBS gene. The frequency of occurrence is 1:100000population. The highest frequency of carriage in the population of the del5 mutation in the NBS gene in the Czech Republic is 1:154, in Ukraine – 1:182, in Poland – 1:190. This pathology is presented in our clinical practice for the first time, and therefore we would like to provide data for a wide review

6 April 2023 in Russian Journal of Allergy
Verified
Journal Article
Closed access
PDF file
EKElena Fedorovna Kovzel
Elena Fedorovna Kovzel
TNTair Temirlanovich Nurpeisov
Tair Temirlanovich Nurpeisov
BGBayan - Gani
Bayan - Gani
SVSvetlana Aleksandrovna Volodchenko
Svetlana Aleksandrovna Volodchenko
ZZZhanagul Zhanatovna Zhamanbaeva
Zhanagul Zhanatovna Zhamanbaeva
ҒБҒани Баян
Ғани Баян
This study revealed primary immunodeficiency developing as a result of a genetically mediated quantitative deficiency or a decrease in the activity of the C1 component complement inhibitor in a family clinical case of patients with genetically confirmed hereditary angioedema, who were living in Taldykorgan, Almaty, Republic of Kazakhstan. Anamnesis data and clinical and laboratory-instrumental indicators were evaluated. In addition to assessing the objective status and general clinical laboratory studies, all patients underwent studies to determine the quantitative content of C4 and C1 inhibitor of the complement component and the presence of a mutation in the SERPING1 gene. The polymorphism of clinical and anamnestic data did not allow timely identification of specific syndromes and determination of a clinical diagnosis. As a result, specific basic treatment, preventive measures, and preventive intervention associated with traumatic life and medical situations were given late, leading to life-threatening conditions. The main clinical manifestations of hereditary angioedema are recurrent dense edema, lasting 25 days. The skin, upper respiratory tract, and gastrointestinal tract are the organs most involved. Clinical manifestations in patients vary dramatically, from the absence of characteristic symptoms to life-threatening edema, leading to death.